Anti-Radiation Medication created for the Star Army of Yamatai in YE 43 by the Yugumo Corporation.

This medication is the primary anti-radiation treatment for most Human and humanoid species.

The Star Army of Yamatai primarily utilizes Diethylenetriaminepentaacetic Acid sublingual tabs ¹⁾ as a chelation agent. It is generally the treatment of choice for exposure to plutonium, uranium and other actinides. It is most effective when applied quickly after exposure. Treatment generally continues daily for twelve days depending on exposure levels. Includes instructions for advanced application where dissolve tabs are combined to be diluted for IV applications.

Alternatively, this same medication can be administered also for exposure to most heavy-metals.

Diethylenetriaminepentaacetic Acid - Tabs
Year of Creation	YE 43
Designer	Yugumo Corporation
Nomenclature	Type 43
Alt. Nomenclature	N.A
Manufacturer	Yugumo Corporation
Fielded by	Yugumo Corporation, Star Army of Yamatai
Availability	Mass Production
1 Sealed Package	30 sublingual tablets
Case of 10,000 Packages	300,000 pills
Price	30 KS/package, 195,000 KS/case unit

Still available is the traditional treatment for exposure is Potassium Iodide. This treatment is not preferred because it only protects the thyroid from radioactive iodine. Suitable for specific and mass distribution during a radiological emergency.

Potassium Iodide Pills 130mg Tablet
Year of Creation	YE 43
Designer	Yugumo Corporation
Nomenclature	Type 43
Alt. Nomenclature	N.A
Manufacturer	Yugumo Corporation
Fielded by	Yugumo Corporation, Star Army of Yamatai
Availability	Mass Production
1 Sealed Package	100 tablets
Case of 10,000 Packages	1,000,000 pills
Price	10 KS/package, 65,000 KS/case unit

Nekovalkyrja and Minkan treatments for radiation exposure generally include the introduction of sterile hemosynthetic fluid. The unexposed femtomachinery in the new hemosynthetic fluid identifies cells containing radioactive isotopes as dysfunctional and eliminate them. Encapsulated waste products are then excreted through the skin and can be collected for disposal.

In the event of exposures on board Star Army of Yamatai vessels and facilities, the treatment can be introduced via aerosol by the Nodal Liquid Conduit System that was introduced in YE 42. Small group or individual treatments can be applied via Hemosynthetic Reconstruction Tube or in the event of field triage, it can be performed through traditional IV transfusion. In low-level exposures, the use of concentrated hemosynthetic pills can be used for treatment.

Concentrated Hemosynthetic Pills
Year of Creation	YE 43
Designer	Ketsurui Zaibatsu
Nomenclature	Type 43
Alt. Nomenclature	N.A
Manufacturer	Ketsurui Zaibatsu
Fielded by	Ketsurui Zaibatsu , Star Army of Yamatai
Availability	Mass Production
1 Sealed Package	30 capsules
Case of 10,000 Packages	300,000 capsules
Price	30 KS/package, 195,000 KS/case unit

Andrew created this article on 2021/01/15 06:50.

• Approved by Wes in this thread.
• Art by Midjourney Bot by Andrew.